News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,588 Results
Type
Article (39792)
Company Profile (271)
Press Release (655525)
Section
Business (205005)
Career Advice (2018)
Deals (35523)
Drug Delivery (95)
Drug Development (81171)
Employer Resources (169)
FDA (16173)
Job Trends (14886)
News (346258)
Policy (32595)
Tag
Academia (2553)
Alliances (49684)
Alzheimer's disease (1321)
Approvals (16154)
Artificial intelligence (199)
Bankruptcy (359)
Best Places to Work (11659)
Biotechnology (190)
Breast cancer (226)
Cancer (1714)
Cardiovascular disease (128)
Career advice (1681)
CAR-T (122)
Cell therapy (355)
Clinical research (65400)
Collaboration (665)
Compensation (370)
COVID-19 (2579)
C-suite (161)
Data (1630)
Diabetes (212)
Diagnostics (6303)
Earnings (85575)
Employer resources (146)
Events (111380)
Executive appointments (567)
FDA (17075)
Funding (606)
Gene therapy (245)
GLP-1 (652)
Government (4371)
Healthcare (18789)
Infectious disease (2691)
Inflammatory bowel disease (124)
Interviews (310)
IPO (16493)
Job creations (3664)
Job search strategy (1432)
Layoffs (443)
Legal (7922)
Lung cancer (255)
Manufacturing (236)
Medical device (13272)
Medtech (13277)
Mergers & acquisitions (19403)
Metabolic disorders (550)
Neuroscience (1728)
NextGen: Class of 2025 (6546)
Non-profit (4487)
Northern California (2094)
Obesity (306)
Opinion (197)
Patents (162)
People (57171)
Phase I (20379)
Phase II (28818)
Phase III (21441)
Pipeline (711)
Postmarket research (2570)
Preclinical (8608)
Radiopharmaceuticals (241)
Rare diseases (322)
Real estate (5944)
Regulatory (21997)
Research institute (2318)
Resumes & cover letters (350)
Southern California (1799)
Startups (3622)
United States (18494)
Vaccines (613)
Weight loss (209)
Date
Today (17)
Last 7 days (595)
Last 30 days (2602)
Last 365 days (34562)
2025 (4444)
2024 (35338)
2023 (40182)
2022 (51290)
2021 (55836)
2020 (54160)
2019 (46645)
2018 (35128)
2017 (32225)
2016 (31632)
2015 (37716)
2014 (31458)
2013 (26511)
2012 (28777)
2011 (29436)
2010 (27531)
Location
Africa (719)
Arizona (211)
Asia (37727)
Australia (6180)
California (4780)
Canada (1716)
China (393)
Colorado (218)
Connecticut (230)
Europe (81007)
Florida (688)
Georgia (165)
Illinois (458)
Indiana (261)
Maryland (740)
Massachusetts (3615)
Michigan (198)
Minnesota (334)
New Jersey (1350)
New York (1360)
North Carolina (834)
Northern California (2094)
Ohio (175)
Pennsylvania (1100)
South America (1096)
Southern California (1799)
Texas (705)
Utah (143)
Washington State (468)
695,588 Results for "ucb biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eye Second Phase III
After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB are planning a second late-stage trial by the end of the year to support a drug application.
November 19, 2024
·
3 min read
·
Tristan Manalac
Alzheimer’s disease
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease.
October 22, 2024
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
UCB Offloads Neurology, Allergy Portfolio in China for $680M
Belgium-based biopharma UCB is selling its Chinese neurology and allergy business to Singapore asset management firm CBC Group and Abu Dhabi investment company Mubadala.
August 26, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx)
January 16, 2025
·
14 min read
Press Releases
Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock
February 18, 2025
·
4 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
Press Releases
UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting
November 26, 2024
·
27 min read
Press Releases
UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting
December 9, 2024
·
22 min read
Drug Development
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa
UCB today announced that The Lancet has published results from the Phase 3 BE HEARD I and BE HEARD II trials evaluating the efficacy and safety of BIMZELX.
May 23, 2024
·
14 min read
Press Releases
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 4, 2025
·
4 min read
1 of 69,559
Next
